AID and Igh switch region-Myc chromosomal translocations

DNA Repair

Volumn 5, Issue 9-10, 2006, Pages 1259-1264

  Unniraman, Shyam ^a   Schatz, David G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activation induced deaminase; Class switch recombination; Lymphoma; Repair; Somatic hypermutation; Translocation

Indexed keywords

CYTIDINE DEAMINASE; IMMUNOGLOBULIN HEAVY CHAIN; MYC PROTEIN;

ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CARCINOGENESIS; CELL SURVIVAL; CHROMOSOME TRANSLOCATION; DNA DAMAGE; DNA STRAND BREAKAGE; ENZYME ACTIVATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENE MUTATION; GENE SWITCHING; GENE TRANSLOCATION; GENETIC RECOMBINATION; HUMAN; INTESTINE LYMPHATIC TISSUE; LARGE CELL LYMPHOMA; LYMPHOCYTE PROLIFERATION; MOLECULAR MECHANICS; NONHUMAN; PLASMACYTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPECTRAL KARYOTYPING; TUMOR GROWTH;

ANIMALS; B-LYMPHOCYTES; CYTIDINE DEAMINASE; DISEASE MODELS, ANIMAL; GENES, IMMUNOGLOBULIN HEAVY CHAIN; GENES, MYC; HUMANS; IMMUNOGLOBULIN SWITCH REGION; MICE; MICE, INBRED BALB C; PLASMACYTOMA; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TRANSLOCATION, GENETIC;

EID: 33748625711     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2006.05.019     Document Type: Article

References (74)

1. Mitelman F. Recurrent chromosome aberrations in cancer. Mutat. Res. 462 (2000) 247-253
2. Kuppers R., and Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20 (2001) 5580-5594
3. Willis T.G., and Dyer M.J. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 96 (2000) 808-822
4. Muramatsu M., Sankaranand V.S., Anant S., Sugai M., Kinoshita K., Davidson N.O., and Honjo T. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274 (1999) 18470-18476
5. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., and Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102 (2000) 553-563
6. Catalan N., Selz F., Imai K., Revy P., Fischer A., and Durandy A. The block in immunoglobulin class switch recombination caused by activation-induced cytidine deaminase deficiency occurs prior to the generation of DNA double strand breaks in switch mu region. J. Immunol. 171 (2003) 2504-2509
7. Maizels N. Immunoglobulin gene diversification. Annu. Rev. Genet. 39 (2005) 23-46
8. Rush J.S., Fugmann S.D., and Schatz D.G. Staggered AID-dependent DNA double strand breaks are the predominant DNA lesions targeted to S mu in Ig class switch recombination. Int. Immunol. 16 (2004) 549-557
9. Petersen S., Casellas R., Reina-San-Martin B., Chen H.T., Difilippantonio M.J., Wilson P.C., Hanitsch L., Celeste A., Muramatsu M., Pilch D.R., Redon C., Ried T., Bonner W.M., Honjo T., Nussenzweig M.C., and Nussenzweig A. AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature 414 (2001) 660-665
10. Kenter A., and Wuerffel R. Immunoglobulin switch recombination may occur by a DNA end-joining mechanism. Ann. N.Y. Acad. Sci. 870 (1999) 206-217
11. Wuerffel R.A., Du J., Thompson R.J., and Kenter A.L. Ig Sgamma3 DNA-specifc double strand breaks are induced in mitogen-activated B cells and are implicated in switch recombination. J. Immunol. 159 (1997) 4139-4144
12. Papavasiliou F.N., and Schatz D.G. The activation-induced deaminase functions in a postcleavage step of the somatic hypermutation process. J. Exp. Med. 195 (2002) 1193-1198
13. Papavasiliou F.N., and Schatz D.G. Cell-cycle-regulated DNA double-stranded breaks in somatic hypermutation of immunoglobulin genes. Nature 408 (2000) 216-221
14. Bross L., Muramatsu M., Kinoshita K., Honjo T., and Jacobs H. DNA double-strand breaks: prior to but not sufficient in targeting hypermutation. J. Exp. Med. 195 (2002) 1187-1192
15. Bross L., Fukita Y., McBlane F., Demolliere C., Rajewsky K., and Jacobs H. DNA double-strand breaks in immunoglobulin genes undergoing somatic hypermutation. Immunity 13 (2000) 589-597
16. Zan H., Wu X., Komori A., Holloman W.K., and Casali P. AID-dependent generation of resected double-strand DNA breaks and recruitment of Rad52/Rad51 in somatic hypermutation. Immunity 18 (2003) 727-738
17. Potter M. Neoplastic development in plasma cells. Immunol. Rev. 194 (2003) 177-195
18. Potter M. Experimental plasmacytomagenesis in mice. Hematol. Oncol. Clin. North Am. 11 (1997) 323-347
19. Potter M., and Wiener F. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis 13 (1992) 1681-1697
20. Potter M., and Maccardle R.C. Histology of developing plasma cell neoplasia induced by mineral oil in Balb/C mice. J. Natl. Cancer Inst. 33 (1964) 497-515
21. Shacter E., Arzadon G.K., and Williams J. Elevation of interleukin-6 in response to a chronic inflammatory stimulus in mice: inhibition by indomethacin. Blood 80 (1992) 194-202
22. Hinson R.M., Williams J.A., and Shacter E. Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 4885-4890
23. Kovalchuk A.L., Kim J.S., Park S.S., Coleman A.E., Ward J.M., Morse H.C., 3rd T., Kishimoto M., Potter S., and Janz. IL-6 transgenic mouse model for extraosseous plasmacytoma. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 1509-1514
24. Kovalchuk A.L., Kishimoto T., and Janz S. Lymph nodes and Peyer's patches of IL-6 transgenic BALB/c mice harbor T(12;15) translocated plasma cells that contain illegitimate exchanges between the immunoglobulin heavy-chain mu locus and c-Myc. Leukemia 14 (2000) 1127-1135
25. Janz S., Muller J., Shaughnessy J., and Potter M. Detection of recombinations between c-Myc and immunoglobulin switch alpha in murine plasma cell tumors and preneoplastic lesions by polymerase chain reaction. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 7361-7365
26. Muller J.R., Jones G.M., Potter M., and Janz S. Detection of immunoglobulin/c-Myc recombinations in mice that are resistant to plasmacytoma induction. Cancer Res. 56 (1996) 419-423
27. Muller J.R., Jones G.M., Janz S., and Potter M. Migration of cells with immunoglobulin/c-Myc recombinations in lymphoid tissues of mice. Blood 89 (1997) 291-296
28. Roschke V., Kopantzev E., Dertzbaugh M., and Rudikoff S. Chromosomal translocations deregulating c-Myc are associated with normal immune responses. Oncogene 14 (1997) 3011-3016
29. Ramiro A.R., Jankovic M., Eisenreich T., Difilippantonio S., Chen-Kiang S., Muramatsu M., Honjo T., Nussenzweig A., and Nussenzweig M.C. AID is required for c-Myc/IgH chromosome translocations in vivo. Cell 118 (2004) 431-438
30. Duquette M.L., Pham P., Goodman M.F., and Maizels N. AID binds to transcription-induced structures in c-Myc that map to regions associated with translocation and hypermutation. Oncogene 24 (2005) 5791-5798
31. Okazaki I.M., Hiai H., Kakazu N., Yamada S., Muramatsu M., Kinoshita K., and Honjo T. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 197 (2003) 1173-1181
32. Franco S., Gostissa M., Zha S., Lombard D.B., Murphy M.M., Zarrin A.A., Yan C., Tepsuporn S., Morales J.C., Adams M.M., Lou Z., Bassing C.H., Manis J.P., Chen J., Carpenter P.B., and Alt F.W. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Mol. Cell 21 (2006) 201-214
33. Ramiro A.R., Jankovic M., Callen E., Difilippantonio S., Chen H.T., McBride K.M., Eisenreich T.R., Chen J., Dickins R.A., Lowe S.W., Nussenzweig A., and Nussenzweig M.C. Role of genomic instability and p53 in AID-induced c-Myc-Igh translocations. Nature (2006)
34. Longerich S., and Storb U. The contested role of uracil DNA glycosylase in immunoglobulin gene diversification. Trends Genet. 21 (2005) 253-256
35. Ward I.M., Reina-San-Martin B., Olaru A., Minn K., Tamada K., Lau J.S., Cascalho M., Chen L., Nussenzweig A., Livak F., Nussenzweig M.C., and Chen J. 53BP1 is required for class switch recombination. J. Cell. Biol. 165 (2004) 459-464
36. Manis J.P., Morales J.C., Xia Z., Kutok J.L., Alt F.W., and Carpenter P.B. 53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination. Nat. Immunol. 5 (2004) 481-487
37. Casellas R., Nussenzweig A., Wuerffel R., Pelanda R., Reichlin A., Suh H., Qin X.F., Besmer E., Kenter A., Rajewsky K., and Nussenzweig M.C. Ku80 is required for immunoglobulin isotype switching. EMBO J. 17 (1998) 2404-2411
38. Bassing C.H., Suh H., Ferguson D.O., Chua K.F., Manis J., Eckersdorff M., Gleason M., Bronson R., Lee C., Alt F.W., and Histone. H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114 (2003) 359-370
39. Celeste A., Difilippantonio S., Difilippantonio M.J., Fernandez-Capetillo O., Pilch D.R., Sedelnikova O.A., Eckhaus M., Ried T., Bonner W.M., and Nussenzweig A. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 114 (2003) 371-383
40. Mai S., and Wiener F. The impact of p53 loss on murine plasmacytoma development. Chromosome Res. 10 (2002) 239-251
41. Elson A., Deng C., Campos-Torres J., Donehower L.A., and Leder P. The MMTV/c-Myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Oncogene 11 (1995) 181-190
42. Blyth K., Terry A., O'Hara M., Baxter E.W., Campbell M., Stewart M., Donehower L.A., Onions D.E., Neil J.C., and Cameron E.R. Synergy between a human c-Myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Oncogene 10 (1995) 1717-1723
43. Hsu B., Marin M.C., el-Naggar A.K., Stephens L.C., Brisbay S., and McDonnell T.J. Evidence that c-Myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. Oncogene 11 (1995) 175-179
44. McCormack S.J., Weaver Z., Deming S., Natarajan G., Torri J., Johnson M.D., Liyanage M., Ried T., and Dickson R.B. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. Oncogene 16 (1998) 2755-2766
45. Wiener F., Silva S., Sugiyama H., Babonits M., and Klein G. The "missing" mouse plasmacytoma (MPC) associated translocation T(15;16) occurs repeatedly in new MPC induction systems. Genes Chromosomes Cancer 2 (1990) 36-43
46. Unniraman S., Zhou S., and Schatz D.G. Identification of an AID-independent pathway for chromosomal translocations between the Igh switch region and Myc. Nat. Immunol. 5 (2004) 1117-1123
47. Ramiro A.R., Jankovic M., and Nussenzweig M.C. Amplifying Igh translocations. Nat. Immunol. 6 (2005) 117
48. Unniraman S., Zhou S., and Schatz D.G. Response to 'Amplifying Igh translocations'. Nat. Immunol. 6 (2005) 118
49. Baar J., and Shulman M.J. The Ig heavy chain switch region is a hotspot for insertion of transfected DNA. J. Immunol. 155 (1995) 1911-1920
50. Kataoka T., Takeda S., and Honjo T. Escherichia coli extract-catalyzed recombination in switch regions of mouse immunoglobulin genes. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 2666-2670
51. Stavnezer J. Immunoglobulin class switching. Curr. Opin. Immunol. 8 (1996) 199-205
52. Nambu Y., Sugai M., Gonda H., Lee C.G., Katakai T., Agata Y., Yokota Y., and Shimizu A. Transcription-coupled events associating with immunoglobulin switch region chromatin. Science 302 (2003) 2137-2140
53. Chaudhuri J., Tian M., Khuong C., Chua K., Pinaud E., and Alt F.W. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422 (2003) 726-730
54. Shinkura R., Tian M., Smith M., Chua K., Fujiwara Y., and Alt F.W. The influence of transcriptional orientation on endogenous switch region function. Nat. Immunol. 4 (2003) 435-441
55. Yu K., Chedin F., Hsieh C.L., Wilson T.E., and Lieber M.R. R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nat. Immunol. 4 (2003) 442-451
56. Daniels G.A., and Lieber M.R. RNA:DNA complex formation upon transcription of immunoglobulin switch regions: implications for the mechanism and regulation of class switch recombination. Nucleic Acids Res. 23 (1995) 5006-5011
57. Tian M., and Alt F.W. Transcription-induced cleavage of immunoglobulin switch regions by nucleotide excision repair nucleases in vitro. J. Biol. Chem. 275 (2000) 24163-24172
58. Sun H., Yabuki A., and Maizels N. A human nuclease specific for G4 DNA. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12444-12449
59. Duquette M.L., Handa P., Vincent J.A., Taylor A.F., and Maizels N. Intracellular transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA. Genes Dev. 18 (2004) 1618-1629
60. Yu K., and Lieber M.R. Nucleic acid structures and enzymes in the immunoglobulin class switch recombination mechanism. DNA Repair (Amst.) 2 (2003) 1163-1174
61. Dudley D.D., Manis J.P., Zarrin A.A., Kaylor L., Tian M., and Alt F.W. Internal IgH class switch region deletions are position-independent and enhanced by AID expression. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 9984-9989
62. Evan G.I., and Littlewood T.D. The role of c-Myc in cell growth. Curr. Opin. Genet. Dev. 3 (1993) 44-49
63. Evan G., and Littlewood T. A matter of life and cell death. Science 281 (1998) 1317-1322
64. Fagarasan S., Muramatsu M., Suzuki K., Nagaoka H., Hiai H., and Honjo T. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 298 (2002) 1424-1427
65. Muto T., Okazaki I.M., Yamada S., Tanaka Y., Kinoshita K., Muramatsu M., Nagaoka H., and Honjo T. Negative regulation of activation-induced cytidine deaminase in B cells. Proc. Natl. Acad. Sci. U.S.A. (2006)
66. Shen H.M., Peters A., Baron B., Zhu X., and Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280 (1998) 1750-1752
67. Pasqualucci L., Migliazza A., Fracchiolla N., William C., Neri A., Baldini L., Chaganti R.S., Klein U., Kuppers R., Rajewsky K., and Dalla-Favera R. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 11816-11821
68. Muschen M., Re D., Jungnickel B., Diehl V., Rajewsky K., and Kuppers R. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J. Exp. Med. 192 (2000) 1833-1840
69. Pasqualucci L., Neumeister P., Goossens T., Nanjangud G., Chaganti R.S., Kuppers R., and Dalla-Favera R. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412 (2001) 341-346
70. Gordon M.S., Kanegai C.M., Doerr J.R., and Wall R. Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a). Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 4126-4131
71. Rossi D., Cerri M., Capello D., Deambrogi C., Berra E., Franceschetti S., Alabiso O., Gloghini A., Paulli M., Carbone A., Pileri S.A., Pasqualucci L., and Gaidano G. Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. Leukemia 19 (2005) 2363-2366
72. Ta V.T., Nagaoka H., Catalan N., Durandy A., Fischer A., Imai K., Nonoyama S., Tashiro J., Ikegawa M., Ito S., Kinoshita K., Muramatsu M., and Honjo T. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat. Immunol. 4 (2003) 843-848
73. Barreto V., Reina-San-Martin B., Ramiro A.R., McBride K.M., and Nussenzweig M.C. C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol. Cell 12 (2003) 501-508
74. Shinkura R., Ito S., Begum N.A., Nagaoka H., Muramatsu M., Kinoshita K., Sakakibara Y., Hijikata H., and Honjo T. Separate domains of AID are required for somatic hypermutation and class-switch recombination. Nat. Immunol. 5 (2004) 707-712